 Premal Trivedi
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Portasystemic Shunt, Transjugular Intrahepatic | 6 | 2025 | 44 | 3.420 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 40 | 2.620 |
Why?
| | Radiology, Interventional | 4 | 2024 | 33 | 2.590 |
Why?
| | Vena Cava Filters | 7 | 2023 | 61 | 2.110 |
Why?
| | Ischemic Attack, Transient | 3 | 2022 | 66 | 2.060 |
Why?
| | Hepatorenal Syndrome | 2 | 2025 | 16 | 1.600 |
Why?
| | Radiology | 3 | 2023 | 181 | 1.460 |
Why?
| | Medicare | 7 | 2022 | 747 | 1.340 |
Why?
| | Practice Patterns, Physicians' | 6 | 2021 | 1312 | 1.230 |
Why?
| | Cholestasis | 2 | 2023 | 232 | 1.230 |
Why?
| | Liver Transplantation | 2 | 2025 | 872 | 1.020 |
Why?
| | Gastrointestinal Hemorrhage | 3 | 2021 | 132 | 1.000 |
Why?
| | Pulmonary Embolism | 4 | 2021 | 222 | 0.950 |
Why?
| | Renal Dialysis | 2 | 2020 | 434 | 0.940 |
Why?
| | Renal Replacement Therapy | 1 | 2025 | 92 | 0.920 |
Why?
| | Radiography, Interventional | 1 | 2025 | 114 | 0.890 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 474 | 0.890 |
Why?
| | Hyperaldosteronism | 1 | 2023 | 7 | 0.840 |
Why?
| | United States | 22 | 2024 | 14696 | 0.830 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2022 | 227 | 0.820 |
Why?
| | Stroke | 2 | 2022 | 1129 | 0.810 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 93 | 0.720 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2021 | 25 | 0.700 |
Why?
| | Treatment Outcome | 13 | 2025 | 10821 | 0.680 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2021 | 91 | 0.660 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 82 | 0.640 |
Why?
| | Specialization | 1 | 2020 | 143 | 0.610 |
Why?
| | Medicine | 1 | 2020 | 120 | 0.600 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 18 | 0.570 |
Why?
| | Neuroimaging | 1 | 2020 | 291 | 0.560 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 42 | 0.560 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2021 | 360 | 0.550 |
Why?
| | Leptin | 2 | 2008 | 233 | 0.520 |
Why?
| | Retrospective Studies | 13 | 2023 | 15628 | 0.500 |
Why?
| | Ascites | 1 | 2016 | 46 | 0.500 |
Why?
| | Healthcare Disparities | 1 | 2022 | 651 | 0.490 |
Why?
| | Lower Extremity | 1 | 2020 | 427 | 0.490 |
Why?
| | Endovascular Procedures | 1 | 2020 | 315 | 0.480 |
Why?
| | Hypertension, Portal | 1 | 2016 | 64 | 0.480 |
Why?
| | Humans | 35 | 2025 | 137514 | 0.480 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2054 | 0.470 |
Why?
| | Logistic Models | 5 | 2021 | 2064 | 0.470 |
Why?
| | Liver Neoplasms | 1 | 2021 | 786 | 0.450 |
Why?
| | Databases, Factual | 6 | 2022 | 1351 | 0.390 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1580 | 0.380 |
Why?
| | Radiography | 3 | 2023 | 834 | 0.370 |
Why?
| | Catheterization | 2 | 2023 | 179 | 0.350 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 242 | 0.350 |
Why?
| | Device Removal | 2 | 2023 | 138 | 0.350 |
Why?
| | Patient Discharge | 3 | 2022 | 895 | 0.340 |
Why?
| | Aged, 80 and over | 7 | 2021 | 7593 | 0.310 |
Why?
| | Apoptosis | 2 | 2008 | 2557 | 0.310 |
Why?
| | Aged | 11 | 2022 | 23798 | 0.310 |
Why?
| | Neoplasms | 1 | 2023 | 2666 | 0.280 |
Why?
| | Muscle Cells | 1 | 2007 | 43 | 0.280 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5427 | 0.270 |
Why?
| | Cardiomegaly | 1 | 2007 | 175 | 0.260 |
Why?
| | Middle Aged | 10 | 2023 | 33355 | 0.250 |
Why?
| | Male | 15 | 2023 | 67718 | 0.250 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 366 | 0.240 |
Why?
| | Hospitals | 2 | 2021 | 678 | 0.230 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 528 | 0.220 |
Why?
| | Cohort Studies | 4 | 2023 | 5730 | 0.210 |
Why?
| | Aldosterone | 1 | 2023 | 44 | 0.210 |
Why?
| | Adrenal Glands | 1 | 2023 | 78 | 0.210 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2838 | 0.200 |
Why?
| | Watchful Waiting | 1 | 2023 | 80 | 0.200 |
Why?
| | Female | 13 | 2023 | 73162 | 0.200 |
Why?
| | Gallbladder Diseases | 1 | 2022 | 12 | 0.200 |
Why?
| | Atherectomy | 1 | 2022 | 37 | 0.190 |
Why?
| | Forecasting | 1 | 2024 | 386 | 0.190 |
Why?
| | Hospitalization | 3 | 2021 | 2197 | 0.190 |
Why?
| | Adult | 8 | 2021 | 37821 | 0.190 |
Why?
| | Cholecystostomy | 1 | 2021 | 4 | 0.180 |
Why?
| | Cholecystitis, Acute | 1 | 2021 | 23 | 0.180 |
Why?
| | Femoral Artery | 1 | 2022 | 178 | 0.180 |
Why?
| | Cholecystectomy | 1 | 2021 | 60 | 0.180 |
Why?
| | Risk Factors | 4 | 2025 | 10356 | 0.170 |
Why?
| | Vena Cava, Inferior | 1 | 2021 | 71 | 0.170 |
Why?
| | Oropharynx | 1 | 2020 | 46 | 0.170 |
Why?
| | Mouth | 1 | 2020 | 86 | 0.170 |
Why?
| | Larynx | 1 | 2020 | 60 | 0.170 |
Why?
| | Hemodynamics | 1 | 2025 | 1114 | 0.170 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.160 |
Why?
| | Cardiologists | 1 | 2020 | 46 | 0.160 |
Why?
| | Radiologists | 1 | 2020 | 50 | 0.160 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2039 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 207 | 0.160 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 65 | 0.160 |
Why?
| | Time Factors | 3 | 2020 | 6817 | 0.150 |
Why?
| | Hemorrhage | 1 | 2023 | 723 | 0.150 |
Why?
| | Odds Ratio | 1 | 2021 | 1063 | 0.150 |
Why?
| | Recurrence | 1 | 2021 | 1060 | 0.150 |
Why?
| | Acute Disease | 1 | 2021 | 1008 | 0.150 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 593 | 0.140 |
Why?
| | Inpatients | 2 | 2019 | 502 | 0.140 |
Why?
| | Socioeconomic Factors | 1 | 2022 | 1286 | 0.140 |
Why?
| | Vascular Patency | 1 | 2018 | 105 | 0.140 |
Why?
| | Radiology Department, Hospital | 1 | 2017 | 15 | 0.140 |
Why?
| | Venous Thromboembolism | 2 | 2018 | 313 | 0.130 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 64 | 0.130 |
Why?
| | Liver Cirrhosis | 1 | 2019 | 316 | 0.130 |
Why?
| | Linear Models | 2 | 2017 | 851 | 0.130 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 153 | 0.130 |
Why?
| | Adolescent | 6 | 2021 | 21555 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 170 | 0.130 |
Why?
| | Inservice Training | 1 | 2017 | 113 | 0.130 |
Why?
| | Cardiovascular Diseases | 1 | 2008 | 2113 | 0.130 |
Why?
| | Personnel Selection | 1 | 2017 | 78 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2020 | 539 | 0.120 |
Why?
| | Surgeons | 1 | 2020 | 298 | 0.120 |
Why?
| | Obesity | 1 | 2008 | 2974 | 0.120 |
Why?
| | Hospital Mortality | 2 | 2018 | 902 | 0.120 |
Why?
| | Comorbidity | 2 | 2018 | 1618 | 0.110 |
Why?
| | Prevalence | 1 | 2021 | 2719 | 0.110 |
Why?
| | Faculty, Medical | 1 | 2017 | 283 | 0.110 |
Why?
| | Biomarkers | 1 | 2025 | 4172 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1079 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2857 | 0.100 |
Why?
| | Anticoagulants | 1 | 2017 | 665 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1524 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1131 | 0.090 |
Why?
| | Young Adult | 4 | 2021 | 13243 | 0.090 |
Why?
| | Sex Factors | 1 | 2018 | 2074 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5139 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2022 | 135 | 0.090 |
Why?
| | Heart Failure | 2 | 2018 | 2222 | 0.080 |
Why?
| | Length of Stay | 1 | 2016 | 1210 | 0.080 |
Why?
| | Positron-Emission Tomography | 2 | 2022 | 299 | 0.080 |
Why?
| | Survival Rate | 2 | 2018 | 1980 | 0.080 |
Why?
| | Rats, Zucker | 1 | 2008 | 34 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2494 | 0.080 |
Why?
| | Mice, Obese | 1 | 2007 | 66 | 0.070 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2007 | 95 | 0.070 |
Why?
| | Caspase 3 | 1 | 2007 | 246 | 0.070 |
Why?
| | Catalysis | 1 | 2007 | 319 | 0.070 |
Why?
| | Intracranial Pressure | 1 | 2006 | 47 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1060 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1950 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2501 | 0.050 |
Why?
| | Myocardium | 1 | 2007 | 1004 | 0.050 |
Why?
| | Interdisciplinary Research | 1 | 2022 | 27 | 0.050 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 98 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 178 | 0.050 |
Why?
| | Gallbladder | 1 | 2021 | 19 | 0.050 |
Why?
| | Brain Injuries | 1 | 2006 | 493 | 0.040 |
Why?
| | Laryngeal Neoplasms | 1 | 2020 | 39 | 0.040 |
Why?
| | Insulin Resistance | 1 | 2008 | 1198 | 0.040 |
Why?
| | Rats | 1 | 2008 | 5676 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 685 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 690 | 0.040 |
Why?
| | Hospital Bed Capacity | 1 | 2018 | 25 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4295 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2018 | 117 | 0.040 |
Why?
| | Hospitals, Urban | 1 | 2018 | 135 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 208 | 0.030 |
Why?
| | Animals | 2 | 2008 | 37011 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 321 | 0.030 |
Why?
| | Signal Transduction | 1 | 2008 | 5096 | 0.030 |
Why?
| | Career Choice | 1 | 2017 | 215 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1241 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 533 | 0.030 |
Why?
| | Age Factors | 1 | 2018 | 3301 | 0.020 |
Why?
| | Mice | 1 | 2007 | 17843 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2870 | 0.020 |
Why?
| | Curriculum | 1 | 2017 | 980 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7598 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5772 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2006 | 106 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2006 | 182 | 0.020 |
Why?
| | Observer Variation | 1 | 2006 | 347 | 0.010 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2006 | 233 | 0.010 |
Why?
| | Child | 2 | 2017 | 22037 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11097 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3292 | 0.010 |
Why?
|
|
Trivedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|